GloveOn COATS Handy Pack

View Product

> Fingertip textured
> Powder Free
> Not made with natural rubber latex
> Chemotherapy drugs tested
> Lab chemical tested
> Ambidextrous
> Standard Cuff
> Dawn blue colour

COATS® (an acronym for Colloidal Oatmeal System) is a patented and unique nitrile glove technology. COATS® utilises the powerful benefits of all-natural oats, an FDA-recognised skin protectant, as a coating that forms a natural, moisturising barrier between the glove and skin. This acts as a preventative measure against skin irritation, and eliminates uncomfortable and irritating conditions experienced when wearing normal gloves. Users who suffer from dry and itchy skin due to frequent hand washing and glove usage can now rely on COATS® to soothe and nurture the skin, and protect their hands while they work.

Reorder Code Size
CTS157SS Small
CTS157MM Medium
CTS157LL Large
Glove PropertiesMeasurement (mm)
Length≥230
Thickness at Palm (centre of Palm)0.07 ± 0.02
Thickness at Finger (13mm ± 3mm from tip)0.09 ± 0.02
Physical PropertiesBefore AgeingAfter Ageing
Tensile Strength (MPa)≥18≥16
Elongation (%)≥500≥400
Inspection Levels and AQLInspection LevelAQL
WatertightnessG11.5
Physical DimensionsS24.0
Tensile StrengthS24.0
Visual Inspection (Major)S42.5
Visual Inspection (Minor)S44.0
Particulate ResidueN=5≤2mg/glove
Packaging  
Configuration200 gloves per box for XS to L
180 gloves per box for XL
10 boxes per carton
Regulatory Compliance 
RegulationsARTG 164563
FDA 510(k)
MDD 93/42/EEC
REACH
ROHS Directive 2002/95/EC
EU 10/2011
EC 1935/2004
EU 2016/425
International Standards 
StandardsASTM D6319
ASTM D5151
ASTM D6124
ASTM D6978
EN ISO 374-1 (Type B)
EN 374 part 2, 4 & 5
EN 16523-1
EN 420
EN 455 part 1, 2, 3 & 4
EN 1186
EN 13130
CEN/TS 14234
ISO 10993 part 5 & 10
HACCP International Certified
Manufacturing Accreditations 
AccreditationsISO 9001
ISO 13485
EN ISO 13485
Chemotherapy Drugs and Concentration
(Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05-Test Report PN 145460)
Minimum Breakthrough Detection Time (minutes)
Carmustine (BCNU), 3.3mg/ml (3,300ppm)16.2
Cisplatin, 1.0mg/ml (1,000ppm)>240
Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm)>240
Dacarbazine (DTIC), 10.0mg/ml (10,000ppm)>240
Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm)>240
Etoposide (Toposar), 20.0mg/ml (20,000ppm)>240
Fluorouracil, 50.0mg/ml (50,000ppm)>240
Methotrexate, 25.0mg/ml (25,000ppm)>240
Mitomycin C, 0.5mg/ml (500ppm)>240
Paclitaxel (Taxol), 6.0mg/ml (6,000ppm)>240
Thiotepa, 10.0mg/ml (10,000ppm)28.4
Vincristine Sulfate, 1.0mg/ml (1,000ppm)>240
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Celeste nitrile glove at 16.2 minutes and 28.4 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.
FEATURED SELLERS
Dentavision
Regional Health Care Group
Protat Logo 2
EBOS Healthcare
Alpha Medical Supplies
Team Medical
Glass Vials Logo
SSS Australia
McFarlane Logo FA-Hero
Vital Medical Supplies
FIND YOUR NEAREST SELLER